Pulmonary Embolism News and Research

RSS
A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung.
COVID-19 survivors can show persistent symptoms six months after recovery, study finds

COVID-19 survivors can show persistent symptoms six months after recovery, study finds

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

FASLG gene may drive cytokine-linked adverse COVID-19 outcomes with age

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Lipid storm in severe COVID-19 linked to high COX/LOX pathway activity

Thromboembolism in COVID-19 patients associated with higher risk of mortality

Thromboembolism in COVID-19 patients associated with higher risk of mortality

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

UIC conducts three clinical trials to study blood clot prevention in COVID-19 patients

Study identifies cardiac structural damage experienced by COVID-19 patients

Study identifies cardiac structural damage experienced by COVID-19 patients

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Study provides in-depth analysis on VTE risk in COVID-19 patients

Study provides in-depth analysis on VTE risk in COVID-19 patients

Study identifies thousands of deaths caused by heart disease and stroke during COVID-19 pandemic

Study identifies thousands of deaths caused by heart disease and stroke during COVID-19 pandemic

Anti-N-protein IgG may predict severity of COVID-19

Anti-N-protein IgG may predict severity of COVID-19

International trial of blood thinners for COVID-19 treatment begins

International trial of blood thinners for COVID-19 treatment begins

Seroconversion marks recovery from COVID-19

Seroconversion marks recovery from COVID-19

High levels of blood clotting factor V in severe COVID‐19 associated with worse outcomes

High levels of blood clotting factor V in severe COVID‐19 associated with worse outcomes

Antibody-mediated platelet death linked to COVID-19 severity

Antibody-mediated platelet death linked to COVID-19 severity

A global study to determine COVID-19 health and psychosocial consequences

A global study to determine COVID-19 health and psychosocial consequences

Hestia criteria, sPESI score can be used to select pulmonary embolism patients for outpatient care

Hestia criteria, sPESI score can be used to select pulmonary embolism patients for outpatient care

Study: Many COVID-19 patients suffer cardiovascular damage even after recovery

Study: Many COVID-19 patients suffer cardiovascular damage even after recovery

Cardiovascular disease in COVID-19

Cardiovascular disease in COVID-19

Researchers achieve bleeding-free anti-coagulation with synthetic inhibitor

Researchers achieve bleeding-free anti-coagulation with synthetic inhibitor